AcceGen

AcceGen is a biotechnology company specializing in cell and genomic research, offering a comprehensive range of cell products and services to support scientific advancements.

Key Products and Services:

  • Primary Cells: AcceGen provides an extensive collection of over 1,200 primary cells derived from both human and animal sources. These cells are essential for various research applications, including molecular biology, biomedicine, drug screening, and toxicology studies. ​
  • Tumor Cell Lines: The company offers a diverse selection of tumor cell lines, facilitating studies on cancer development, immunotherapy, and targeted therapies. ​
  • Stem Cells: AcceGen supplies various stem cell types, including embryonic stem cells, adult stem cells, cancer stem cells, and induced pluripotent stem cells (iPSCs), to support regenerative medicine and developmental research. ​
  • Immortalized Cell Lines: They offer approximately 60 immortalized cell lines from human, mouse, and rat origins, providing stable models for extended research applications. ​
  • Transfected Stable Cell Lines: AcceGen provides custom stable cell lines with specific genetic modifications, including knockout, knockin, knockdown, overexpression, and reporter constructs, to meet diverse research needs. ​
  • MicroRNA Agomir/Antagomir: They offer chemically modified microRNA mimics (Agomir) and inhibitors (Antagomir) for gene regulation studies, aiding in the exploration of miRNA functions in various biological processes. ​
  • Custom Services: AcceGen extends services such as custom stable cell line development, iPSC gene editing, cell and gene therapeutic solutions, cell immortalization, microRNA sponge construction, and microRNA Agomir/Antagomir synthesis to cater to specific research requirements.